The agreement is focuses on the anti-ageing cosmetic active HydroxysomesCalcium and will mean that through the partnership with Laboratory Skin Care, the ingredient will be marketed as a co-brand under the name Roancare Hydroxysomes Calcium.
The terms of the contract mean that this marketing agreement and rebranding will take effect from October 2014, and in the meantime Merck says it will gradually take on the responsibility for the marketing, sales and logistics concerning the ingredient.
Mechanism transport calcium deeper into the skin
Marketed as an anti-ageing ingredient, the substance has been developed based on a mechanism that transports calcium into deep layers of the skin, ultimately revitalizing it and helping to alleviate signs of skin ageing.
The ingredient has been developed behind the idea that calcium feeds and regenerates the skin, particularly in more mature individuals.
In particular, the ingredient is said to accelerate the regeneration mechanism by driving the calcium into deeper layers of the skin than have previously been observed in other calcium-based ingredients.
Enhanced regenerative and moisture effect
This means that the regeneration effect on the skin barrier is enhanced, in turn helping to maintain vital levels of moisture in the skin more effectively.
Merck has entered into the partnership because it believes that the ingredient will be a good addition to its portfolio of patent-protected and globally-approved anti-ageing active cosmetic ingredients.
“Such scientific alliances are very important to us. We establish them to complement our own research activities, which recently generated highly interesting cosmetic active ingredients – for example Ronacare Bronzyl and Ronacare Pristine Bright,” said Michael Weiden, Head of Functional Materials within the Pigments & Cosmetics business unit.